# OnCo record autx-703 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/autx-703/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "autx-703" ;
  schema:name "AUTX-703"@en ;
  schema:description "AUTX-703 is an experimental small-molecule protein degrader from Auron Therapeutics, in phase 1 trials for acute myeloid leukaemia, myelodysplastic syndrome and small cell lung cancer and other cancers."@en ;
  schema:url <https://onco.cc/drugs/autx-703/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://aurontx.com/programs-and-pipeline>, <https://aurontx.com/programs-and-pipeline>, <https://aurontx.com/programs-and-pipeline>, <https://clinicaltrials.gov/api/v2/studies/NCT06846606>, <https://clinicaltrials.gov/search?intr=AUTX-703> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small-molecule protein degrader (oral)" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds/> ;
  onco:targets <https://onco.cc/targets/kat2a/>, <https://onco.cc/targets/kat2b/> ;
  onco:companies <https://onco.cc/companies/auron-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06846606/> .